Citadel Advisors - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,785,357
-74.8%
406,796
-58.3%
0.00%
-80.0%
Q2 2023$26,923,810
-28.9%
974,794
-40.8%
0.01%
-37.5%
Q1 2023$37,869,040
+28.2%
1,646,480
-39.2%
0.01%
+14.3%
Q4 2022$29,538,978
+191.0%
2,707,514
+124.8%
0.01%
+133.3%
Q3 2022$10,152,000
+95.4%
1,204,187
+83.4%
0.00%
+200.0%
Q2 2022$5,195,000
-39.2%
656,729
+81.9%
0.00%
-50.0%
Q1 2022$8,549,000
+70.1%
361,024
+145.7%
0.00%
Q4 2021$5,026,000
-33.6%
146,948
-65.6%
0.00%
-100.0%
Q3 2021$7,574,000
-60.7%
427,404
-0.5%
0.00%
-75.0%
Q2 2021$19,277,000
+257.5%
429,508
+106.3%
0.00%
+300.0%
Q1 2021$5,392,000
-21.5%
208,218
-38.9%
0.00%
-50.0%
Q4 2020$6,871,000
+107.4%
340,822
-27.4%
0.00%
+100.0%
Q1 2020$3,313,000
+2.4%
469,212
+2.2%
0.00%0.0%
Q4 2019$3,236,000
-35.3%
459,093
+10.3%
0.00%
-50.0%
Q3 2019$4,999,000
+0.7%
416,255
+1.6%
0.00%0.0%
Q2 2019$4,963,000
+8.6%
409,847
+12.7%
0.00%0.0%
Q1 2019$4,572,000
+1853.8%
363,727
+946.3%
0.00%
Q4 2018$234,000
-36.4%
34,762
-2.8%
0.00%
Q3 2018$368,000
-58.3%
35,757
-72.8%
0.00%
Q2 2018$883,000
+108.7%
131,401
+167.1%
0.00%
Q1 2018$423,00049,1970.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$56,331,20918.32%
Kynam Capital Management, LP 1,375,000$31,625,0004.08%
BVF INC/IL 3,775,900$86,845,7003.18%
Cormorant Asset Management, LP 1,700,000$39,1002.58%
RTW INVESTMENTS, LP 4,600,799$105,818,3772.20%
Ghost Tree Capital, LLC 225,000$5,175,0001.53%
683 Capital Management, LLC 791,000$18,193,0001.36%
Ikarian Capital, LLC 211,400$4,862,2001.10%
Ikarian Capital, LLC 211,400$4,862,2001.10%
SILVERARC CAPITAL MANAGEMENT, LLC 105,486$2,426,1781.00%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders